1. Home
  2. COCP vs RETO Comparison

COCP vs RETO Comparison

Compare COCP & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • RETO
  • Stock Information
  • Founded
  • COCP N/A
  • RETO 1999
  • Country
  • COCP United States
  • RETO China
  • Employees
  • COCP N/A
  • RETO N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • COCP Health Care
  • RETO Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • RETO Nasdaq
  • Market Cap
  • COCP 18.3M
  • RETO 19.9M
  • IPO Year
  • COCP N/A
  • RETO 2017
  • Fundamental
  • Price
  • COCP $1.99
  • RETO $0.94
  • Analyst Decision
  • COCP Strong Buy
  • RETO
  • Analyst Count
  • COCP 1
  • RETO 0
  • Target Price
  • COCP $7.00
  • RETO N/A
  • AVG Volume (30 Days)
  • COCP 14.9K
  • RETO 43.5K
  • Earning Date
  • COCP 11-13-2024
  • RETO 12-30-2024
  • Dividend Yield
  • COCP N/A
  • RETO N/A
  • EPS Growth
  • COCP N/A
  • RETO N/A
  • EPS
  • COCP N/A
  • RETO N/A
  • Revenue
  • COCP N/A
  • RETO $3,841,142.00
  • Revenue This Year
  • COCP N/A
  • RETO N/A
  • Revenue Next Year
  • COCP N/A
  • RETO N/A
  • P/E Ratio
  • COCP N/A
  • RETO N/A
  • Revenue Growth
  • COCP N/A
  • RETO N/A
  • 52 Week Low
  • COCP $1.33
  • RETO $0.86
  • 52 Week High
  • COCP $3.10
  • RETO $5.00
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.27
  • RETO 45.89
  • Support Level
  • COCP $1.83
  • RETO $0.91
  • Resistance Level
  • COCP $2.07
  • RETO $1.10
  • Average True Range (ATR)
  • COCP 0.11
  • RETO 0.07
  • MACD
  • COCP -0.01
  • RETO 0.01
  • Stochastic Oscillator
  • COCP 44.74
  • RETO 47.83

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: